Scientific Program
March 28 (Thursday)
- [JS01] Joint Session 01: Asian hematology session I - EBV-associated lymphoid malignancy Room 1
-
- March 28 (Thursday), 09:00-10:15
- Ki Seong Eom (The Catholic University of Korea College of Medicine, Korea), Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
-
09:00-09:25
Prospective studies for NK/T-cell lymphoma in Asia
Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
09:25-09:50
Chronic active EBV disease: Our challenge to elucidate the pathogenesis
Ayako Arai (St. Marianna University School of Medicine, Japan)
09:50-10:15
NK lymphoma genomics
Weili Zhao (Shanghai Jiao Tong University School of Medicine, China)
- [ES01] Education Session 01: Histiocytic neoplasm Room 2
-
- March 28 (Thursday), 09:00-10:15
- Nack-Gyun Chung (The Catholic University of Korea College of Medicine, Korea), Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
-
09:00-09:25
Histiocytic neoplasm in pediatrics
Kyung-Nam Koh (University of Ulsan College of Medicine, Korea)
09:25-09:50
Histiocytic sarcoma
Sungnam Lim (Inje University College of Medicine, Korea)
09:50-10:15
Pathologic characteristics of histiocytic neoplasm
Sun Och Yoon (Yonsei University College of Medicine, Korea)
- [SS01] Scientific Session 01: Exploring the utilization of innovative technologies Room 3
-
- March 28 (Thursday), 09:00-10:15
- Young Kyung Lee (Hallym University College of Medicine, Korea), Yoon Hwan Chang (Seoul National University College of Medicine, Korea)
-
09:00-09:25
Elucidating the 3D chromatin landscape of pediatric B-cell acute lymphoblastic leukemia using Micro-C
Kajsa Paulsson (Lund University, Sweden)
09:25-09:50
Integrated RNA and protein profiling of B-cell acute lymphoblastic leukemia at single-cell level
Sungyoung Choi (Hanyang University College of Medicine, Korea)
09:50-10:15
Leveraging dysregulated signaling networks for therapeutic benefit in myeloproliferative neoplasm
Stephen T. Oh (Washington University School of Medicine, USA)
- [SS02] Scientific Session 02: The unmet needs in CML - Overcoming the obstacles of the road to cure Room 4
-
- March 28 (Thursday), 09:00-10:15
- Chul Won Jung (Sungkyunkwan University School of Medicine, Korea), Hawk Kim (Gachon University College of Medicine, Korea)
-
09:00-09:25
Molecular mechanism of primary TKI resistance in CML
Jerald Radich (Fred Hutchinson Cancer Center, USA)
09:25-09:50
Targeting leukemic stem cells in CML
Mhairi Copland (University of Glasgow, UK)
09:50-10:15
The role of NGS to detect TKI resistance
Saeam Shin (Yonsei University College of Medicine, Korea)
- [PL01] Plenary Lecture 01 Room 1+2
-
- March 28 (Thursday), 10:30-11:15
- Seoklae Chae (Dongguk University College of Medicine, Korea)
-
10:30-11:15
Somatic mutations and clonal dynamics in human blood cells
Peter J. Campbell (Wellcome Sanger Institute, UK)
- [PS01] Presidential Symposium 01 Room 1+2
-
- March 28 (Thursday), 11:15-12:00
- Seongsoo Jang (University of Ulsan College of Medicine, Korea)
-
11:15–12:00
Lab-on-a-chip in hematology
Chong H. Ahn (University of Cincinnati, USA)
- [SY01] Satellite Symposium 01: Janssen Room 1
-
- March 28 (Thursday), 12:15-13:05
- Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
-
12:15-13:05
Treatment of newly diagnosed multiple myeloma: Focus on daratumumab combination
Elena Zamagni (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy)
- [SY02] Satellite Symposium 02: Astrazeneca Room 2
-
- March 28 (Thursday), 12:15-13:05
- Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
-
12:15-13:05
The ultimate value of C5 inhibitors in the evolving treatment landscape of PNH
Sung-Hyun Kim (Dong-A University College of Medicine, Korea)
- [SY03] Satellite Symposium 03: Astellas Room 3
-
- March 28 (Thursday), 12:15-13:05
- Hee-Je Kim (The Catholic University of Korea College of Medicine, Korea)
-
12:15-13:05
Treatment strategies for elderly AML with FLT3-mutation, entering the era of FLT3 Inhibitors
Naoko Hosono (University of Fukui, Japan)
- [SY04] Satellite Symposium 04: Roche Room 4
-
- March 28 (Thursday), 12:15-13:05
- Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
-
12:15-13:05
Advances in the treatment paradigm with bispecific antibodies
Wendy Osborne (Newcastle University, UK)
- [JS02] Joint Session 02: EHA-KSH Joint Symposium - Multiple Myeloma Room 1
-
- March 28 (Thursday), 15:30-16:45
- Jin Seok Kim (Yonsei University College of Medicine, Korea), Meral Beksac (Ankara Liv Hospital, Türkiye)
-
15:30-15:46
Dynamic assessment of risk in multiple myeloma
Meral Beksac (Ankara Liv Hospital, Türkiye)
15:46-16:02
PET/CT for risk stratification in multiple myeloma
Joon Ho Moon (Kyungpook National University School of Medicine, Korea)
16:02-16:18
Bone marrow inflammation in multiple myeloma
Tom Cupedo (Erasmus MC Cancer Center, The Netherlands)
16:18-16:34
Single-cell analysis in multiple myeloma
Sung-Soo Park (The Catholic University of Korea College of Medicine, Korea)
- [SS03] Scientific Session 03: Wise perspective on new approaches in hemophilia Room 2
-
- March 28 (Thursday), 15:30-16:45
- Eun Jin Choi (Daegu Catholic University School of Medicine, Korea), Young Shil Park (Kyung Hee University College of Medicine, Korea)
-
15:30-15:55
Approaches to treat people with hemophilia: What’s new and what’s not?
Leonard Valentino (The National Bleeding Disorders Foundation (NBDF) , USA)
15:55-16:20
Prospects and challenges of gene therapy for hemophilia
Alok Srivastava (Christian Medical College, India)
16:20-16:45
Exploring personalized tailored hemophilia treatment
Jeong A Park (Inha University College of Medicine, Korea)
- [SS04] Scientific Session 04: For the next generation CAR-T cells Room 3
-
- March 28 (Thursday), 15:30-16:45
- Seok-Goo Cho (The Catholic University of Korea College of Medicine, Korea), Je-Jung Lee (Chonnam National University Medical School, Korea)
-
15:30-15:55
CD7 CAR-T therapy for treating hematological maligancies
Peihua Lu (Lu Daopei Hospital, China)
15:55-16:20
Development of a novel anti-CD19 CAR-T cells in B cell lymphoma
Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
16:20-16:45
CAR T cells for treatment of T cell malignancies
Paul M. Maciocia (Cancer Research UK , UK)
- [SS05] Scientific Session 05: Deepened understanding of AML using multi-omics approaches Room 4
-
- March 28 (Thursday), 15:30-16:45
- Hyeoung-Joon Kim (Chonnam National University Medical School, Korea), Myung-Shin Kim (The Catholic University of Korea College of Medicine, Korea)
-
15:30-15:55
Navigating cancer complexities via single-cell omics and AI
Manoj Bhasin (Emory University, USA)
15:55-16:20
Targeting the developmental heterogeneity of human acute myeloid leukemia
Shanshan Pei (Zhejiang University, China)
16:20-16:45
Mutational profile in Korean AML patients
Jae-Sook Ahn (Chonnam National University Medical School, Korea)
- [SS06] Scientific Session 06: Insights into lymphoma pathobiology Room 1
-
- March 28 (Thursday), 16:55-18:10
- Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea), Gyeong-Sin Park (The Catholic University of Korea College of Medicine, Korea)
-
16:55-17:20
Germinal center in the genesis of lymphomas
Laura Pasqualucci (Columbia University, USA)
17:20-17:45
Genomics of follicular lymphoma: Clinical implications?
Robert Kridel (University Health Network, Canada)
17:45-18:10
Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression
Jin Ho Paik (Seoul National University College of Medicine, Korea)
- [SS07] Scientific Session 07: Profound understanding of diagnosis and therapy in MDS Room 2
-
- March 28 (Thursday), 16:55-18:10
- Yoo Jin Kim (The Catholic University of Korea College of Medicine, Korea), Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
-
16:55-17:20
Molecular alterations and clinical implications in MDS
Yasushi Miyazaki (Nagasaki University, Japan)
17:20-17:45
Recent advances and future therapeutic strategies in MDS
Guillermo Garcia-Manero (The University of Texas MD Anderson Cancer Center, USA)
17:45-18:10
Current diagnostic challenges of MDS
In-Suk Kim (Pusan National University Yangsan Hospital, Korea)
- [SS08] Scientific Session 08: Leukemogenesis in children and adults Room 3
-
- March 28 (Thursday), 16:55-18:10
- Kyung Ha Ryu (Ewha Womans University College of Medicine, Korea), Hoon Kook (Chonnam National University Medical School, Korea)
-
16:55-17:20
RUNX1-FPDMM natural history study at NIH
Pu Paul Liu (National Institutes of Health, USA)
17:20-17:45
Clinical impact of DDX41 mutations in myeloid neoplasms
Talha Badar (Mayo Clinic, USA)
17:45-18:10
Discovery of new regulators in hematopoietic stem cells and malignancies
Dongjun Lee (Pusan National University School of Medicine, Korea)
- [ES02] Education Session 02: Basics for trainees (Kor) Room 4
-
- March 28 (Thursday), 16:55-18:10
- Inho Kim (Seoul National University College of Medicine, Korea), Jaewoo Song (Yonsei University College of Medicine, Korea)
-
16:55-17:20
Overview of lymphoma classification
Tae-Jung Kim (The Catholic University of Korea College of Medicine, Korea)
17:20-17:45
What's new in AML classification
Hee Sue Park (Chungbuk National University College of Medicine, Korea)
17:45-18:10
Recent update of MDS classification
MiYoung Kim (University of Ulsan College of Medicine, Korea)
March 29 (Friday)
- [JS03] Joint Session 03: ASH-KSH Joint Symposium - Ped-ALL Room 1
-
- March 29 (Friday), 09:00-10:15
- Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea), Wendy Stock (University of Chicago, USA)
-
09:00-09:16
Pediatric and AYA ALL: Lessons learned from children’s oncology group clinical trials
Sarah K. Tasian (The Children’s Hospital of Philadelphia, USA)
09:16-09:32
Multicenter trials investigating childhood acute lymphoblastic leukemia in South Korea
Hyery Kim (University of Ulsan College of Medicine, Korea)
09:32-09:48
Dissecting the Developmental Origins of Acute Leukemia
Charles G. Mullighan (St. Jude Children’s Research Hospital, USA)
09:48-10:04
Unveiling precision medicine: RNA and DNA sequencing in targeted therapy for Korean pediatric leukemia
Myung-Shin Kim (The Catholic University of Korea College of Medicine, Korea)
- [ES03] Education Session 03: Leaps and hurdles in transfusion medicine (Kor) Room 2
-
- March 29 (Friday), 09:00-10:15
- Duck Cho (Sungkyunkwan University School of Medicine, Korea), Jihyang Lim (The Catholic University of Korea College of Medicine, Korea)
-
09:00-09:25
Comprehensive overview of cell-based artificial platelet production
Seung Yeob Lee (Jeonbuk National University Medical School, Korea)
09:25-09:50
Anti-CD38 and anti-CD47 delay timely transfusion
Hyungsuk Kim (Seoul National University College of Medicine, Korea)
09:50-10:15
Reappraisal of transfusion-transmitted infections
Dae-Hyun Ko (University of Ulsan College of Medicine, Korea)
- [SS09] Scientific Session 09: Clonal hematopoiesis: What should we know? Room 3
-
- March 29 (Friday), 09:00-10:15
- Myung Geun Shin (Chonnam National University Medical School, Korea), Hyun Kyung Kim (Seoul National University College of Medicine, Korea)
-
09:00-09:25
Clonal hematopoiesis and aging
Siddhartha Jaiswal (Stanford University School of Medicine, USA)
09:25-09:50
Clonal hematopoiesis: Implications for cell therapy
Adam S. Sperling (Dana-Farber Cancer Institute, USA)
09:50-10:15
Clonal Hematopoiesis and Metabolic Disorders
Sung Hee Choi (Seoul National University College of Medicine, Korea)
- [SS10] Scientific Session 10: Predictive biomarkers in multiple myeloma Room 4
-
- March 29 (Friday), 09:00-10:15
- Chang-Ki Min (The Catholic University of Korea College of Medicine, Korea), Jeong Yeal Ahn (Gachon University College of Medicine, Korea)
-
09:00-09:25
The impact of immune profiling of T-cell and plasma cells on non-cellular immune therapy in myeloma
Nizar J Bahlis (University of Calgary, Canada)
09:25-09:50
Single-cell techniques to characterize immune microenvironment in MM
Niels Weinhold (Univ Hosp Heidelberg, Germany)
09:50-10:15
The power of ONE: Immunology in the age of single cell genomics
Ido Amit (Weizmann Institute of Science, Israel)
- [PL02] Plenary Lecture 02 Room 1+2
-
- March 29 (Friday), 10:30-11:15
- Chuhl Joo Lyu (Yonsei University College of Medicine, Korea)
-
10:30–11:15
How to win: Competitive strategies in the hematopoietic stem cell niche
Margaret Goodell (Baylor College of Medicine, USA)
- [SY05] Satellite Symposium 05: BMS Room 1
-
- March 29 (Friday), 12:15-13:05
- Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
-
12:15-13:05
Continued hope with ONUREG - A new maintenance therapy to treat AML
Esther Oliva (Grande Ospedale Metropolitano Bianchi Melacrino Morelli)
- [SY06] Satellite Symposium 06: Kyowa Kirin Room 2
-
- March 29 (Friday), 12:15-13:05
- Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
-
12:15-13:05
Mogamulizumab: A new era in MF/SS management - Clinical evidence and practical consideration
Francine Foss (Yale University School of Medicine)
- [SY07] Satellite Symposium 07: Novartis Room 3
-
- March 29 (Friday), 12:15-13:05
- Dong-Wook Kim (Eulji University School of Medicine, Korea)
-
12:15-13:05
TKI treatment pattern and new therapy of CML
Qian Jiang (Peking University People's Hospital)
- [SY08] Satellite Symposium 08: Handok Room 4
-
- March 29 (Friday), 12:15-13:05
- Hyeon-Seok Eom (National Cancer Center, Korea)
-
12:15-13:05
The optimal treatment strategy for transplant-ineligible relapsed/refractory DLBCL
Kwai Han Yoo (Gachon University College of Medicine)
- [JS04] Joint Session 04: Current interests in hematologic disease in Asia Room 1
-
- March 29 (Friday), 15:05-16:20
- Soo-Mee Bang (Seoul National University College of Medicine, Korea), Byeong-Bae Park (Hanyang University College of Medicine, Korea)
-
15:05-15:25
The journey of bone marrow transplantation at BachMai General Hospital
Han Viet Trung (Journey of transplantation in Bach Mai General Hospital, Vietnam)
15:25-15:45
Current situation of management of non-hodgkin lymphoma in the Republic of Armenia
Yervand Hakobyan (Armenian Hematology Association, Armenia)
15:55-16:20
The evolution of hemophilia treatment in Thailand
Darintr Sosothikul (Chulalongkorn University, Thailand)
- [SS11] Scientific Session 11: Quality-of-life revisited Room 2
-
- March 29 (Friday), 15:05-16:20
- Sung Yong Oh (Dong-A University College of Medicine, Korea), Yong Park (Korea University College of Medicine, Korea)
-
15:05-15:30
End-of-life care in children with hematologic malignancies
Min Sun Kim (Seoul National University College of Medicine, Korea)
15:30-15:55
Long-term survivorship in hematologic malignancies
Shahrukh K. Hashmi (Mayo Clinic, USA)
15:55-16:20
The importance of monitoring symptoms and quality of life in routine hematology practice
Fabio Efficace (Italian Group for Adult Hematologic Diseases, Italy)
- [SS12] Scientific Session 12: Novel approaches for diagnosis & treatment of acute lymphoblastic leukemia Room 3
-
- March 29 (Friday), 15:05-16:20
- Hyoung Jin Kang (Seoul National University College of Medicine, Korea), Ho-Jin Shin (Pusan National University School of Medicine, Korea)
-
15:05-15:30
Novel approaches for diagnosis & treatment of acute lymphoblastic and myeloid leukemia
Michel Zwaan (Princess Ma´xima Center for Pediatric Oncology, The Netherlands)
15:30-15:55
The role of blinatumomab in the treatment of MRD negative B-ALL in adults
Mark R. Litzow (Mayo Clinic, USA)
15:55-16:20
Revised WHO classification of ALL: New era of genetic diagnosis
Ari Ahn (The Catholic University of Korea College of Medicine, Korea)
- [ES04] Education Session 04: Monoclonal gammopathies of clinical significance Room 4
-
- March 29 (Friday), 15:05-16:20
- Young Rok Do (Keimyung University School of Medicine, Korea), Hyo Jung Kim (Hallym University College of Medicine, Korea)
-
15:05-15:30
AL cardiac amyloidosis
Darae Kim (Sungkyunkwan University School of Medicine, Korea)
15:30-15:55
Nephrologist’s perspective on monoclonal gammopathy of renal significance
Soon Hyo Kwon (Soonchunhyang University College of Medicine, Korea)
15:55-16:20
Monoclonal gammopathies of neurological significance
Ju-Hong Min (Sungkyunkwan University School of Medicine, Korea)
- [SS13] Scientific Session 13: Advancing in knowledge of rare pediatric hematologic disorders Room 2
-
- March 29 (Friday), 16:35-17:50
- Ho Joon Im (University of Ulsan College of Medicine, Korea), Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea)
-
16:35-17:00
Clonal evolution of MDS/AML in patients with cancer predisposition syndromes
Kenichi Yoshida (National Cancer Center Research Institute, Japan)
17:00-17:25
Congenital & aquired thrombophilic conditions in children
Leonardo R. Brandão (University of Toronto, Canada)
17:25-17:50
Management of rare pediatric lymphomas
Jae Wook Lee (The Catholic University of Korea College of Medicine, Korea)
- [JS05] Joint Session 05: Asian Hematology Session II - AML Room 3
-
- March 29 (Friday), 16:35-17:50
- Sangkyun Sohn (Kyungpook National University School of Medicine, Korea), Byong Soo Kim (Korea University College of Medicine, Korea)
-
16:35-16:55
Epidemiology, risk stratification and treatment outcome in acute myeloid treatment: Taiwan experience
Hsin-An Hou (National Taiwan University, Taiwan)
16:55-17:15
Advancement in leukaemia diagnostics: the role of next-generation sequencing (NGS) in acute myeloid leukaemia in Malaysia
Angeli Ambayya (Ministry of Health, Malaysia)
17:15-17:35
Determining fitness for treatments in older adults with AML
Byung Sik Cho (The Catholic University of Korea College of Medicine, Korea)
- [ES05] Education Session 05: Principles of anticoagulation - All about blood clots (Kor) Room 4
-
- March 29 (Friday), 16:35-17:50
- Soo-Mee Bang (Seoul National University College of Medicine, Korea), Sung Hwa Bae (Daegu Catholic University School of Medicine, Korea)
-
16:35-17:00
Back to the basic: coagulation pathway
Seonyang Park (Inje University Haeundae Paik Hospital, Korea)
17:00-17:25
Pharmacology: Anticoagulants and reversal agents
Seo-Yeon Ahn (Chonnam National University College of Medicine, Korea)
17:25-17:50
Proper application of anticoagulation therapy on CAT
Ho-Young Yhim (Jeonbuk National University Medical School, Korea)
March 30 (Saturday)
- [ES06] Education Session 06: Essential knowledge for optimal hematologic consultation (Kor) Room 1
-
- March 30 (Saturday), 09:00-10:15
- Jong Ho Won (Soonchunhyang University College of Medicine, Korea), Deog-Yeon Jo (Chungnam National University College of Medicine, Korea)
-
09:00-09:25
Functional iron deficiency in cancer patients
Ik-Chan Song (Chungnam National University Medical School, Korea)
09:25-09:50
Assessment of neutropenia in hospitalized patients
Young Hoon Park (Ewha Womans University College of Medicine, Korea)
09:50-10:15
Perioperative consultation for the appropriate transfusion
Ka-Won Kang (Korea University College of Mecine, Korea)
- [SS14] Scientific Session 14: Novel insights into pathogenesis of MPN Room 2
-
- March 30 (Saturday), 09:00-10:15
- Chul Won Choi (Korea University College of Mecine, Korea), Sung-Yong Kim (Konkuk University School of Medicine, Korea)
-
09:00-09:25
Myeloproliferative neoplasms and inflammation
Steffen Koschmieder (RWTH Aachen University, Germany)
09:25-09:50
Signaling contributing to the development of myelofibrosis: Beyond JAK/STAT
Douglas Tremblay (Mount Sinai School of Medicine, USA)
09:50-10:15
Clonal evolution in myelofibrosis
Sung-Eun Lee (The Catholic University of Korea College of Medicine, Korea)
- [SS15] Scientific Session 15: Immunotherapies for lymphomas non-benefited from CAR-T cell therapy Room 3
-
- March 30 (Saturday), 09:00-10:15
- Jae-Yong Kwak (Jeonbuk National University Medical School, Korea), Deok-Hwan Yang (Chonnam National University Medical School, Korea)
-
09:00-09:25
Treatment options for relapsed/refractory hodgkin lymphoma after brentuximab vedotin and PD-1 blockade
Alex F. Herrera (City of Hope, USA)
09:25-09:50
Aggressive B-cell lymphomas: Immuno-chemotherapies other than CAR-T cell therapies
Jason Westin (MD Anderson Cancer Center, USA)
09:50-10:15
Extranodal NK/T cell lymphoma: the immunogenic tumor
Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
- [ES07] Education Session 07: Basic genomics for clinical hematologists (Kor) Room 4
-
- March 30 (Saturday), 09:00-10:15
- Hee-Jin Kim (Sungkyunkwan University School of Medicine, Korea), In-Suk Kim (Pusan National University Yangsan Hospital, Korea)
-
09:00-09:25
Genomic technologies for detecting structural variations in hematologic malignancies
Mi-Ae Jang (Sungkyunkwan University School of Medicine, Korea)
09:25-09:50
The role of NGS in hematologic malignancies
Young-Uk Cho (University of ulsan College of Medicine, Korea)
09:50-10:15
Germline predisposition to hematologic malignancies
Sang Mee Hwang (Seoul National University College of Medicine, Korea)
Sponsored by